Published in Gene Therapy Weekly, October 11th, 2001
Their analysis of the activity of genes in breast tumor samples, as revealed by a laboratory tool known as a "DNA microarray," demonstrated that researchers could discriminate the tumors' status regarding two clinically important factors - estrogen receptor status and lymph node status.
Tumors whose cells show the presence of estrogen receptors are more likely to spread aggressively, as they respond to growth-inducing estrogen and progesterone. Also, the ability to predict whether...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.